Showing results (1371-1380 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|June 12, 2023
Pharmacogenomic markers of metoprolol and α-OH-metoprolol concentrations: a genome-wide association studyJean Laverdière, Maxime Meloche, Sylvie Provost, et al.Pharmacogenomics|July 22, 2026
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIVZinhle Cindi, Katie M Cardone, Yuki Bradford, et al.Pharmacogenomics|April 19, 2026
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancerOluwaferanmi Bello, Olivia Rieur, Neelima VidulaPharmacogenomics|April 17, 2026
The future of pharmacogenomics in cardiovascular medicineMarianna Danielli, Nicole Benfield, Helen R Warren, et al.Pharmacogenomics|August 3, 2026
U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazoleBrock Beins, Hans Salcedo, Gloria Grice, et al.Pharmacogenomics|September 28, 2026
Process evaluation of a pharmacogenomic informed antidepressant prescribing intervention delivered in primary care: findings from the PRESIDE (PhaRmacogEnomicS in Depression) trialGeorgia Ramsay, Madeline Luke, Philip Ly, et al.Pharmacogenomics|October 24, 2026
Genetic polymorphisms of GLUT1 (rs841853) and MATE1 (rs2289669) are associated with metformin response in type 2 diabetes mellitusAsma Imran Ansari, Mohammad Abbas, Aliya Abbas Rizvi, et al.Pharmacogenomics|October 30, 2026
Fall-risk in genetic variable cytochrome P450 enzymes and exposure to anticholinergic drugs - a pilot-analysis from the ADRED-studyKatja S Just, Thea Laurentius, Alyssa Büttgenbach, et al.Pharmacogenomics|July 2, 2003
What is next in pharmacogenomics? Translating it to clinical practiceRoland Valdes, Mark W Linder, Saeed A JortaniPharmacogenomics|July 2, 2003
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugsToshiyuki Sakaeda, Tsutomu Nakamura, Katsuhiko OkumuraPageof 276